How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

ABOS Insider Trading (Acumen Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $5,560,000.00
Insider Selling (Last 12 Months): $0.00

Acumen Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Acumen Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acumen Pharmaceuticals Share Price & Price History

Current Price: $3.59
Price Change: Price Increase of +0.36 (11.15%)
As of 05/17/2022 02:57 PM ET

This chart shows the closing price history over time for ABOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How the Pros Choose Their Stocks
Grab your seat at our free, LIVE, masterclass for traders.

It’s your chance to learn how to pick the right stocks and find the market bottom.

We’ll reveal 3 Tips for dodging volatility and a few under-the-radar stocks we believe have significant potential in the long run.
Click here now to register.

Acumen Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/6/2021John A. Stalfort, IIIDirectorBuy35,000$16.00$560,000.00View SEC Filing Icon  
7/6/2021Paul B. ManningMajor ShareholderBuy312,500$16.00$5,000,000.00View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

SEC Filings (Institutional Ownership Changes) for Acumen Pharmaceuticals (NASDAQ:ABOS)

64.42% of Acumen Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ABOS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Acumen Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Great Point Partners LLC928,282$3.63M0.9%N/A2.292%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System12,162$48K0.0%+114.9%0.030%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.334,195$1.31M0.0%+3.4%0.825%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP501,236$1.96M0.0%+4.3%1.238%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP2,599,098$10.16M0.7%+34.5%6.418%Search for SEC Filing on Google Icon
5/16/2022State Street Corp184,858$0.72M0.0%+66.0%0.456%Search for SEC Filing on Google Icon
5/16/2022Prelude Capital Management LLC15,600$61K0.0%N/A0.039%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp216,168$0.85M0.0%+127.6%0.534%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.63,251$0.25M0.0%+163.1%0.156%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.14,047$55K0.0%+163.3%0.035%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,234,771$4.83M0.0%+122.5%3.049%Search for SEC Filing on Google Icon
5/13/2022Fiduciary Group LLC10,000$31K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.3,831,321$14.98M0.0%+23.2%9.461%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers20,273$79K0.0%N/A0.050%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp68,971$0.27M0.0%+259.6%0.170%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.18,049$71K0.0%+149.3%0.045%Search for SEC Filing on Google Icon
5/10/2022WMS Partners LLC181,068$0.71M0.1%N/A0.447%Search for SEC Filing on Google Icon
5/6/2022Los Angeles Capital Management LLC56,592$0.22M0.0%N/A0.140%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund23,981$94K0.0%+337.5%0.059%Search for SEC Filing on Google Icon
4/21/2022Strs Ohio41,300$0.16M0.0%+24.0%0.102%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.3,109,670$21.02M0.0%+8.4%7.684%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP480,681$3.25M0.0%+2.5%1.188%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.323,264$2.19M0.0%+408.0%0.799%Search for SEC Filing on Google Icon
2/15/2022Chicago Partners Investment Group LLC17,960$92K0.0%+21.3%0.044%Search for SEC Filing on Google Icon
2/15/2022Schonfeld Strategic Advisors LLC86,543$0.59M0.0%N/A0.214%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC37,163$0.25M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC11,545$78K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.27,167$0.18M0.0%+48.3%0.067%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC74,523$0.50M0.0%+89.4%0.184%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC18,818$0.13M0.0%N/A0.046%Search for SEC Filing on Google Icon
2/14/2022State Street Corp111,363$0.75M0.0%+11.6%0.275%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.323,264$2.19M0.0%+408.0%0.799%Search for SEC Filing on Google Icon
2/14/2022Deep Track Capital LP1,933,040$13.07M0.9%N/A4.776%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC171,879$1.16M0.0%+59.4%0.425%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC21,609$0.15M0.0%N/A0.053%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.7,240$49K0.0%+97.2%0.018%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.3,891$26K0.0%+255.7%0.010%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE21,095$0.14M0.0%+2,030.8%0.052%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp94,984$0.64M0.0%+8.7%0.235%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund5,481$37K0.0%N/A0.014%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio33,300$0.23M0.0%+1,413.6%0.082%Search for SEC Filing on Google Icon
11/19/2021American International Group Inc.5,247$78K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp17,945$0.27M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/16/2021Janus Henderson Group PLC860,181$12.77M0.0%N/A2.126%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP656,848$9.76M0.0%N/A1.623%Search for SEC Filing on Google Icon
11/16/2021Moore Capital Management LP369,583$5.49M0.1%N/A0.913%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL289,663$4.30M0.2%N/A0.716%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC39,346$0.59M0.0%N/A0.097%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System5,180$77K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC75,000$1.12M0.0%N/A0.185%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP1,579,191$23.47M0.5%N/A3.902%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP156,250$2.32M0.0%N/A0.386%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.9,770,773$145.19M2.0%N/A24.144%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.937,500$13.93M0.0%N/A2.317%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC107,806$1.60M0.0%N/A0.266%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.63,635$0.95M0.0%N/A0.157%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.2,868,791$42.63M0.0%N/A7.089%Search for SEC Filing on Google Icon
11/4/2021Sands Capital Ventures LLC3,417,075$50.78M7.7%N/A8.444%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG5,518$82K0.0%N/A0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Acumen Pharmaceuticals logo
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Read More on Acumen Pharmaceuticals

Today's Range

Now: $3.59
Low: $3.38
High: $3.60

50 Day Range

MA: $4.42
Low: $3.08
High: $6.41

52 Week Range

Now: $3.59
Low: $3.02
High: $26.98

Volume

4,550 shs

Average Volume

190,105 shs

Market Capitalization

$145.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Acumen Pharmaceuticals?

Acumen Pharmaceuticals' top insider shareholders include:
  1. John A Stalfort III (Director)
  2. Marc Benioff (CEO)
  3. Nathan B Fountain (Director)
  4. Paul B Manning (Director)
  5. Paul B Manning (Major Shareholder)
  6. Sands Capital Global Venture F (Major Shareholder)
Learn More about top insider investors at Acumen Pharmaceuticals.

Who are the major institutional investors of Acumen Pharmaceuticals?

Acumen Pharmaceuticals' top institutional investors include:
  1. BlackRock Inc. — 9.46%
  2. Deep Track Capital LP — 6.42%
  3. Vanguard Group Inc. — 3.05%
  4. Great Point Partners LLC — 2.29%
  5. Woodline Partners LP — 1.24%
  6. Goldman Sachs Group Inc. — 0.83%
Learn More about top institutional investors of Acumen Pharmaceuticals stock.

Which major investors are buying Acumen Pharmaceuticals stock?

Within the previous quarter, ABOS stock was purchased by institutional investors including:
  1. Great Point Partners LLC
  2. BlackRock Inc.
  3. Vanguard Group Inc.
  4. Deep Track Capital LP
  5. WMS Partners LLC
  6. Northern Trust Corp
  7. State Street Corp
  8. Los Angeles Capital Management LLC
During the last year, these company insiders have bought Acumen Pharmaceuticals stock:
  1. John A Stalfort III (Director)
  2. Marc Benioff (CEO)
  3. Nathan B Fountain (Director)
  4. Paul B Manning (Director)
Learn More investors buying Acumen Pharmaceuticals stock.
3 Tips for Surviving a Market Crash
Protect your capital and get back on track with your trading goals with artificial intelligence.

Grab your seat at our FREE, LIVE online class.

Learn today how to navigate volatility and choppy markets.
Save your spot now!